Metformin Hydrochloride Tablet, Extended Release
Product Images NDC 65841-027

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 65841-027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

500 mg (95f617f7 2d62 4c77 B0cc 1b2c3dcffcbd 01)

Label for METFORMIN HYDROCHLORIDE Extended-Release Tablets, USP 500 mg by Cadila Healthcare Limited. The label indicates the product contains 500 tablets, with directions for the pharmacist to dispense patient information separately. Storage instructions specify 20° to 25°C (68° to 77°F) and use of a light-resistant container. The label includes warnings to keep out of reach of children and states the product is prescription only (Rx only).*

FDA Label Image

750 mg (95f617f7 2d62 4c77 B0cc 1b2c3dcffcbd 02)

METFORMIN HYDROCHLORIDE EXTENDED-RELEASE Tablets, USP 750 mg by Cadila Healthcare Limited. The label indicates the product is an extended-release metformin hydrochloride tablet in a package containing 500 tablets. It includes storage instructions, dispensing information, and a note that the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.